# Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity

> **NCT02683317** · NA · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 110 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DIETARY_SUPPLEMENT:** docosahexaenoic acid
- **DIETARY_SUPPLEMENT:** sunflower oil

## Key facts

- **NCT ID:** NCT02683317
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-22
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-10-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02683317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02683317, "Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02683317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*